Home » Topics » BioWorld Science

BioWorld Science
RSS

GT Biopharma provides clinical update for two phase I/II studies of GTB-1550

May 31, 2019

Shionogi & Co. patents new antibacterial compounds

May 31, 2019

First-in-human data for M-2000 in patients with early-stage breast cancer

May 31, 2019

Nonclinical toxicology studies support long-term administration of oral ibrexafungerp

May 31, 2019

Patient recruitment ongoing in phase I study of BOS-475

May 31, 2019

Beijing Jialin Pharmaceutical discovers SMARCA2-targeting drugs for cancer

May 31, 2019

Shanghai ECUST Biomedicine patents tubulin polymerization inhibitors

May 31, 2019

CSIR synthesizes new TLR9 antagonists

May 31, 2019

Takeda identifies hSTING agonists

May 31, 2019

Inflazome patents new NLRP3 inflammasome inhibitors

May 31, 2019

Popular Stories

Today's news in brief
BioWorld
SCAN is core circuit affected in Parkinson’s disease
BioWorld Science
Parkinson’s disease (PD) is a neurodegenerative disorder that affects movement, and tremor is one of its signatures. But it is a much more wide-ranging disorder,...
TL1A is overexpressed in hidradenitis suppurativa
BioWorld Science
Despite the availability of advanced therapeutic options, about 40%-50% of patients with hidradenitis suppurativa do not achieve significant improvement in...
IL-22 and TL1A, a robust couple for diagnosing hidradenitis suppurativa
BioWorld Science
Hidradenitis suppurativa (HS) is a chronic inflammatory skin disease with strong association with psoriasis and inflammatory bowel disease (IBD). While some...
Inhibiting the NLRP3 inflammasome for cognitive impairment, stroke
BioWorld Science
Vascular cognitive impairment and dementia (VCID) and cerebral small vessel disease are among the leading causes of dementia, where inflammation is known to play...